Amalgamated Financial’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Amalgamated Financial’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$39K	Buy	+2,029	New	+$36.2K	﹤0.01%	2533

Other funds holding DICE

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Amalgamated Financial's DICE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2022: 2,029 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #2533 among its holdings.

76 funds tracked by Wall St. Rank hold DICE as of Q1 2022.

Amalgamated Financial held 2,029 shares of DICE Therapeutics, Inc. Common Stock worth $39K as of Q1 2022.
DICE Therapeutics, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
DICE Therapeutics, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2533 holding.
76 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.